Publication

Article

Pharmaceutical Technology

Pharmaceutical Technology, January 2023
Volume47
Issue 1
Pages: 12

Biologics-Oriented Antibody Discovery Platform

Author(s):

Pharmaceutical Technology Editors

Bio-Rad Laboratories’ Pioneer Antibody Discovery Platform is an antibody discovery service specifically designed to develop best-in-class biologic candidates.

Bio-Rad Laboratories Pioneer Antibody Discovery Platform is an antibody discovery service specifically designed to develop best-in-class biologic candidates. The platform, which includes more than 200 billion unique sequences, is capable of identifying high-affinity antibody candidates via Bio-Rad’s SpyDisplay selection technology; this technology is optimized for candidates suitable for drug development.

The platform is tailored to specific client requirements and uses proprietary TrailBlazer technology to provide prototypes of therapeutic antibodies in various formats for streamlined lead identification. Final immunoglobulin G antibodies are delivered functionally characterized with a complete data package and sequences. Customers retain exclusivity and ownership over antibody sequences produced from the platform.

Bio-Rad Laboratories

Download Issue PDF
Articles in this issue
Six Approaches Making the Most Significant Impact in the Future
Six Approaches Making the Most Significant Impact in the Future
European industry trends
Opening Up Opportunities in 2023
Inhalation Vaccine Development
Inhalation Vaccine Development
Crossing the Same River Multiple Times
Crossing the Same River Multiple Times
Predicting Pharma’s Future
Predicting Pharma’s Future
Write it Down, Investigate, and Control
Write it Down, Investigate, and Control
check box | Image Credit: © bigpa - stock.adobe.com
Cleaning Up in Bio/Pharma
Sustainability in Europe pharma
Setting Goals for Sustainability
The Growth and Emergence of Technology in the Outsourcing Space
The Growth and Emergence of Technology in the Outsourcing Space
A Rocky Road Ahead for FDA and Industry
A Rocky Road Ahead for FDA and Industry
Packaging Formats Evolve
Packaging Formats Evolve
Considerations for Manufacturing Solid Versus Semi-solid Drugs
Considerations for Manufacturing Solid Versus Semi-solid Drugs
Pedestrians as Priority
Creative image of embryonic stem cells, cellular therapy. 3d illustration | Image Credit: © pinkeyes- stock.adobe.com
Frontrunners in the Latest Stem Cell Technology
Getting Personal for Blockbusters in 2023

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!
Related Videos
A global supply chain map, visualizing the complex network of transportation routes and distribution centers | Image Credit: © venusvi - stock.adobe.com
Shortcut from point A to point B | Image Credit: © Olivier Le Moal - stock.adobe.com
Wooden blocks spelling TARIFFS are placed on a map of North America, specifically over the United States and Mexico | Image Credit: © Rokas - stock.adobe.com
Simona Guidi, Associate Director, ProPharma
Behind the Headlines, Episode 18
Drug Digest: Patient Preference Drives Solid Dosage Trends
Behind the Headlines, Episode 17
Related Content
Futuristic health tech. A smartwatch projects a holographic health dashboard, providing real-time body analytics and vital signs monitoring anytime, anywhere. | Image Credit: © woravut - stock.adobe.com
August 5th 2025

How FDA’s ISTAND Initiative Supports Innovative Tools in Drug Discovery and Development

Patrick Lavery
The program has been transitioned to a permanent pathway that is designed to support innovative tools like artificial intelligence, wearables, and biomarkers in drug development and trials.
Drug Solutions Podcast: Growth and Advancements in Fill/Finish
August 5th 2025

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Felicity Thomas
In this episode, Hanns-Christian Mahler from ten23 Health chats about the advances in fill/finish.
Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com
August 5th 2025

FDA Changes Opioid Pain Medication Labeling Requirements

Susan Haigney
The changes, required for safety labeling of all opioid drugs, will emphasize the risks with long-term use to combat misuse and addiction.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
August 5th 2025

Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines

Feliza Mirasol
In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Glass vials for liquid samples. | Image Credit: ©nordroden - stock.adobe.com
August 5th 2025

Flexibility Provides Solutions to Small-Batch Manufacturing Challenges

Susan Haigney
Modular process design, single-use technologies, and flexible filling lines are some of the ways manufacturers can combat challenges involved in small-batch manufacturing.
medicine factory scientist worker work in Laboratory Plants Process. medical doctor working research in pharmaceutical industry. | Image Credit: ©Quality Stock Arts – stock.adobe.com
August 5th 2025

Interfering with Interventions in Aseptic Processing

James Agalloco
Addressing human interventions to reduce their impact on contamination requires addressing broader considerations than limiting operator activities. Equipment, automation, procedural and component changes can be utilized to make the aseptic activities safer. This article offers suggestions for reducing the adverse impact of intervention throughout the aseptic process.